Development of Fenofibrate/Randomly Methylated β-Cyclodextrin-Loaded Eudragit^® RL 100 Nanoparticles for Ocular Delivery

Fenofibrate (FE) has been shown to markedly reduce the progression of diabetic retinopathy and age-related macular degeneration in clinical trials and animal models. Owing to the limited aqueous solubility of FE, it may hamper ocular bioavailability and result in low efficiency to treat such disease...

Descripció completa

Dades bibliogràfiques

Autors principals:	Soe Yadanar Khin, Hay Man Saung Hnin Soe, Chaisak Chansriniyom, Natapol Pornputtapong, Rathapon Asasutjarit, Thorsteinn Loftsson, Phatsawee Jansook
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2022-07-01
Col·lecció:	Molecules
Matèries:	cyclodextrin fenofibrate complexation eye drops: nanocarriers permeation
Accés en línia:	https://www.mdpi.com/1420-3049/27/15/4755
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!